• About
  • Board
  • News
  • Sign Up
  • Contact

Visit

VJHemOnc
Logo
  • Home (current)
  • Diseases
    ALL
    AML
    CLL
    Lymphoma
    Multiple Myeloma
    Myeloproliferative Neoplasms
    View all Diseases
  • Topics
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    Transplantation
    View all Topics
  • Conferences
    ASH
    2018
    UKONS
    2018
    ERIC
    2018
    BOPA
    2018
    ESH MM
    2018
    EORTC CLTF
    2018
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

monotherapy

4:15
Venetoclax monotherapy for relapsed/refractory Waldenström’s macroglobulinemia
Jorge Castillo
3:56
RADIUS results: midostaurin reduces relapse after ASCT in FLT3-ITD AML
Richard Thomas Maziarz
2:25
Beat AML: promising results with enasidenib for AML in the frontline
Eytan Stein
1:31
Duvelisib after progression on ofatumumab in R/R CLL: DUO crossover extension study
Matthew Davids
1:13
Achieving longer remissions with venetoclax monotherapy in R/R CLL
William Wierda
2:58
A big year for CLL: ibrutinib updates from ASH
William Wierda
2:02
Monoallelic TP53-mutated CLL patients show durable response to ibrutinib monotherapy
Carsten Niemann
2:08
7-year follow-up of ibrutinib monotherapy for R/R and first-line CLL
Susan O’Brien
0:55
Long-term follow-up of acalabrutinib in R/R mantle cell lymphoma
Simon Rule
2:35
Stapled peptide ALRN-6924 for AML and MDS
David Sallman
0:48
DUO results: duvelisib or ofatumumab monotherapy for R/R CLL?
Stephan Stilgenbauer
2:04
A novel mechanism of action for daratumumab in myeloma
Niels van de Donk
1:46
CD38 antibodies under investigation for myeloma: isatuximab, MOR202 & TAK-079
Niels van de Donk
2:49
Daratumumab in myeloma update: expanding indications
Niels van de Donk
1:53
The promising role of IDH inhibitors in AML
Amir Fathi
2:32
Improving the treatment landscape for DLBCL patients
Andrés Ferreri
  • 1
  • 2
  • 3
  • Next
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

Please enter your details if you would like to receive the latest Hemonc news and updates

Continue
Video channels
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Acute Promyelocytic Leukemia
  • Amyloidosis
  • Anemia
  • Aplastic Anemia
  • B-Cell Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • CNS Lymphoma
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use